Serum levels of TAG 72 and CA 15.3 in patients with gynaecological neoplasms

M. Correale, I. Abbate, A. Catino, T. Tedone, M. D. Musci, D. Dragone, G. Gargano, G. Izzi, A. Cramarossa

Research output: Contribution to journalArticlepeer-review


In the present report we have evaluted two new serum tumour markers identified by monoclonal antibodies: TAG 72 and CA 15.3 in 62 patients with gynaecological carcinomas, in prevalence ovarian and 36 women with benign gynaecological diseases. Serum levels of both markers were determined using two immunoradiometric assays and the cut-off values were set at 5 U/mL for TAG 72 and at 40 U/mL for CA 15.3. In our study the sensitivity was 57% for TAG 72 and 43% for CA 15.3 with a specificity of 97% and 89% respectively. Even if these two markers show a sensitivity lower than CA 125, these preliminary results seem to suggest the possible role of TAG 72 and CA 15.3 both as confirmatory tests and as adjunctive tests, especially the first for its excellent specificity.

Original languageEnglish
Pages (from-to)82-84
Number of pages3
JournalEuropean Journal of Gynaecological Oncology
Issue numberSUPPL. 1
Publication statusPublished - 1992

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology


Dive into the research topics of 'Serum levels of TAG 72 and CA 15.3 in patients with gynaecological neoplasms'. Together they form a unique fingerprint.

Cite this